Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Mar 21, 2019; 25(11): 1378-1386
Published online Mar 21, 2019. doi: 10.3748/wjg.v25.i11.1378
Table 1 Clinical background, gastric cancer detection rates, and the details of the two groups before matching
Ultrathin endoscopeConventional endoscopeP value
Number of screened subjects140235
Transnasal41 (29.3%)0 (0%)-
Sedation16 (11.4%)74 (31.5%)< 0.001
Age in yr, median (range)74 (43-89)73 (43-93)0.49
Gender, male99 (70.7%)187 (79.6%)0.05
Helicobacter pylori positive6 (4.3%)9 (3.8%)0.83
Atrophy, open type108 (77.1%)197 (83.8%)0.11
Operator (expert/nonexpert)99/41178/570.28
Number of gastric cancer1220
Number of subjects with gastric cancer/detection rate12 (8.6%)18 (7.7%)0.75
Location (U/M, L)4/4, 43/11, 60.22
Size in mm, median (range)5 (3-30)6.5 (3-18)0.37
Morphological type (I, IIa/IIb, IIc)0, 6/0, 62, 6/0, 120.09
Depth of invasion (m/sm)10/220/00.06